The Company's Holidays for the Year 2024

The rights of shareholders to propose agenda items in advance for the 2024 Annual General Meeting ("AGM")

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023

Financial Performance Quarter 3 (F45) (Reviewed)

Financial Statement Quarter 3/2023 (Reviewed)

Resolutions of the BOD Meeting No.4/2023 regarding the approval of the financial statements for the Q3/2023 ended 30 September 2023, the amendments to the scope of duties and responsibilities of ARCG and the establishment of a new overseas subsidiary

Reporting on the progress of the establishment of a new subsidiary

Reporting on the progress of the establishment of a new subsidiary

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023

Financial Performance Quarter 2 (F45) (Reviewed)

Financial Statement Quarter 2/2023 (Reviewed)

Resolutions of BOD Meeting No.3/2023 regarding the approval of the financial statements for the 2nd quarter of 2023 ended 30 June 2023 and capital increase of a subsidiary company

Industry group and sector reclassification of BIOTEC MINT NEX TWPC and WAVE

Financial Statement Quarter 1/2023 (Reviewed) (Revised the Note to interim consolidated financial statements No.14.4)

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2023

Financial Performance Quarter 1 (F45) (Reviewed)

Financial Statement Quarter 1/2023 (Reviewed)

Resolutions of the Board of Director's Meeting No.2/2023 regarding the approval of the financial statements for the first quarter of 2023 ended 31 March 2023 and an establishment of a new overseas subsidiary

Submission of the Minutes of the 2023 Annual General Meeting of Shareholders to the Stock Exchange of Thailand and Disclosure of the Minutes on the Company's Website

Reporting on the progress of the establishment of a new subsidiary